I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Atezolizumab and Bevacizumab in Patients with Unresectable ..:
Shemesh, Colby S.
;
Chan, Phyllis
;
Shao, Hui
...
Liver Cancer. 10 (2021) 5 - p. 485-499 , 2021
Link:
https://doi.org/10.1159/000515817
RT Journal T1
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region
UL https://suche.suub.uni-bremen.de/peid=cr-10.1159_000515817&Exemplar=1&LAN=DE A1 Shemesh, Colby S. A1 Chan, Phyllis A1 Shao, Hui A1 Xu, Derek-Zhen A1 Combs, Daniel A1 Vadhavkar, Shweta A1 Bruno, René A1 Wu, Benjamin PB S. Karger AG YR 2021 SN 2235-1795 SN 1664-5553 JF Liver Cancer VO 10 IS 5 SP 485 OP 499 LK http://dx.doi.org/https://doi.org/10.1159/000515817 DO https://doi.org/10.1159/000515817 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)